As the U.S. stock market rebounds with major indices like the Dow Jones and S&P 500 posting gains, investors are keenly observing opportunities amidst eased geopolitical tensions and stable economic indicators. In this environment, identifying undervalued stocks becomes crucial, as they present potential value by trading below their estimated worth while offering resilience against market fluctuations.
Top 10 Undervalued Stocks Based On Cash Flows In The United StatesNameCurrent PriceFair Value (Est)Discount (Est)TowneBank (TOWN)$36.53$72.3349.5%Seven Hills Realty Trust (SEVN)$9.20$18.2049.4%Old National Bancorp (ONB)$24.02$47.6849.6%Motorcar Parts of America (MPAA)$13.42$26.2548.9%Krystal Biotech (KRYS)$286.00$556.5048.6%Huntington Bancshares (HBAN)$18.77$36.4048.4%Elastic (ESTC)$69.52$135.1748.6%Comstock Resources (CRK)$24.03$46.7448.6%Atlassian (TEAM)$122.41$241.5849.3%Alpha Metallurgical Resources (AMR)$234.89$464.6649.4%
Here we highlight a subset of our preferred stocks from the screener.
Overview: Old National Bancorp is a bank holding company for Old National Bank, offering consumer and commercial banking services in the United States, with a market cap of $8.95 billion.
Operations: Old National Bancorp generates its revenue through consumer and commercial banking services within the United States.
Estimated Discount To Fair Value: 49.6%
Old National Bancorp is trading at US$24.02, significantly below its estimated future cash flow value of US$47.68, highlighting potential undervaluation based on cash flows. Earnings are forecast to grow 23.35% annually, outpacing the broader U.S. market’s growth expectations of 16.1%. Despite recent shareholder dilution and low return on equity projections, the company’s strong net interest income growth and ongoing share buyback program underscore its financial resilience and commitment to enhancing shareholder value.
Overview: Repligen Corporation is a life sciences company that develops and commercializes bioprocessing technologies and systems globally, with a market cap of approximately $9.19 billion.
Operations: Repligen generates revenue primarily from its Medical Products segment, which amounted to $707.89 million.
Estimated Discount To Fair Value: 27.3%
Repligen is trading at US$169.97, below its estimated future cash flow value of US$233.89, indicating potential undervaluation based on cash flows. Earnings are expected to grow significantly at 37.5% annually, surpassing the U.S. market’s growth rate of 16.1%. Despite insider selling and low projected return on equity, Repligen remains focused on innovation with new chromatography resins and seeks M&A opportunities to bolster its market position and financial performance further.
Overview: On Holding AG develops and distributes sports products globally, with a market capitalization of approximately $14.71 billion.
Operations: The company’s revenue primarily comes from its athletic footwear segment, generating CHF 2.88 billion.
Estimated Discount To Fair Value: 16.5%
On Holding is trading at US$46.30, below its estimated future cash flow value of US$55.44, reflecting potential undervaluation based on cash flows. Earnings are projected to grow significantly at 34% annually, outpacing the U.S. market’s growth rate of 16.1%. Despite a modest discount to fair value and slower revenue growth forecasted at 16.4% per year, recent strong earnings performance and raised guidance underscore robust financial health and promising outlooks for investors focused on cash flows.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.
It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com